As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
Ron George
Advertisement
Ron George, PhD, is director of Science and Technology at Lachman Consultants, r.george@lachmanconsultants.com
Articles by Ron George
Data governance is necessary for compliance with current regulatory expectations for data integrity in pharmaceutical R&D and manufacturing organizations.
Advertisement
Latest Updated Articles
Establishing an Effective Data Governance SystemPublished: November 2nd 2017 | Updated:
- Taking a Holistic Approach for Data Governance
Published: December 6th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Standardizing Operations to Meet Global Sustainability and Resilience Goals
2
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
3
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
